Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$510M |
| 2 |
Pfizer
PFE
|
+$265M |
| 3 |
Gilead Sciences
GILD
|
+$212M |
| 4 |
Comcast
CMCSA
|
+$191M |
| 5 |
Meta Platforms (Facebook)
META
|
+$184M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$369M |
| 2 |
SIAL
SIGMA - ALDRICH CORP
SIAL
|
+$330M |
| 3 |
MJN
Mead Johnson Nutrition Company
MJN
|
+$230M |
| 4 |
Amgen
AMGN
|
+$223M |
| 5 |
Teva Pharmaceuticals
TEVA
|
+$145M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.46% |
| 2 | Healthcare | 12.72% |
| 3 | Financials | 10.51% |
| 4 | Industrials | 9.69% |
| 5 | Consumer Staples | 9.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2101
Rithm Capital
RITM
$5.51B
| $2.02M | ﹤0.01% |
166,205
-1,062,600
| -86% | -$13.1M |
|
2102
Distribution Solutions Group
DSGR
$1.6B
| $2.02M | ﹤0.01% |
173,000
+45,800
| +36% | +$602K |
|
2103
Northrim BanCorp
NRIM
$586M
| $2.02M | ﹤0.01% |
303,624
+88,024
| +41% | +$623K |
|
2104
Aware
AWRE
$24.9M
| $2.02M | ﹤0.01% |
619,100
+16,600
| +3% | +$53.1K |
|
|
ZGNX
2105
DELISTED
Zogenix, Inc.
ZGNX
| $2.02M | ﹤0.01% |
136,887
+1,600
| +1% | +$21.5K |
|
2106
RCI Hospitality Holdings
RICK
$197M
| $2.02M | ﹤0.01% |
201,900
+58,100
| +40% | +$581K |
|
2107
Timberland Bancorp
TSBK
$349M
| $2.01M | ﹤0.01% |
162,000
+2,400
| +2% | +$28.5K |
|
|
DSCI
2108
DELISTED
Derma Sciences, Inc. Common Stock (DE)
DSCI
| $2.01M | ﹤0.01% |
439,300
+158,300
| +56% | +$751K |
|
2109
Agilent Technologies
A
$39.2B
| $2.01M | ﹤0.01% |
+48,000
| New | +$1.86M |
|
2110
Cabot Corp
CBT
$4.55B
| $2M | ﹤0.01% |
49,000
+21,800
| +80% | +$862K |
|
2111
Regions Financial
RF
$26.3B
| $2M | ﹤0.01% |
+208,500
| New | +$2M |
|
|
SDLP
2112
DELISTED
SEADRILL PARTNERS LLC
SDLP
| $2M | ﹤0.01% |
+54,836
| New | +$4.67M |
|
2113
BBVA Argentina
BBAR
$4.04B
| $2M | ﹤0.01% |
+104,700
| New | +$2.1M |
|
|
FMER
2114
DELISTED
FIRSTMERIT CORP
FMER
| $2M | ﹤0.01% |
+107,000
| New | +$2.04M |
|
2115
NovaGold Resources
NG
$2.66B
| $1.99M | ﹤0.01% |
473,000
+448,800
| +1,855% | +$1.72M |
|
|
HIL
2116
DELISTED
Hill International, Inc. Common Stock
HIL
| $1.99M | ﹤0.01% |
512,900
-11,900
| -2% | -$41.5K |
|
2117
Foster
FSTR
$431M
| $1.98M | ﹤0.01% |
145,100
-38,781
| -21% | -$528K |
|
2118
Frequency Electronics
FEIM
$591M
| $1.98M | ﹤0.01% |
186,200
+3,100
| +2% | +$32.4K |
|
|
ACAT
2119
DELISTED
Arctic Cat Inc
ACAT
| $1.97M | ﹤0.01% |
120,326
+68,326
| +131% | +$1.41M |
|
2120
Harvard Bioscience
HBIO
$27.5M
| $1.97M | ﹤0.01% |
56,680
-3,430
| -6% | -$117K |
|
2121
AstroNova
ALOT
$224M
| $1.96M | ﹤0.01% |
135,950
+1,300
| +1% | +$17.5K |
|
2122
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.3B
| $1.96M | ﹤0.01% |
38,900
+23,100
| +146% | +$1.15M |
|
2123
HCI Group
HCI
$2.32B
| $1.96M | ﹤0.01% |
+56,300
| New | +$2.2M |
|
2124
NACCO Industries
NC
$356M
| $1.96M | ﹤0.01% |
203,531
+12,773
| +7% | +$130K |
|
|
INVX
2125
Innovex International
INVX
$1.85B
| $1.96M | ﹤0.01% |
+33,000
| New | +$2.05M |
|
Similar funds
Renaissance Technologies's Q4 2015 Portfolio in Review
As of Q4 2015, Renaissance Technologies held 3,639 positions worth $45.9B, up 9.5% from $41.9B the previous quarter. Its ten largest holdings account for 9.3% of the portfolio.
Renaissance Technologies deployed $3.07B of net new capital in Q4 2015, opening 509 new positions and adding to 1,872 existing holdings. Its largest new stake was Apple: 17,852,932 shares worth $470M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 11% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Alphabet (Google) Class C, an estimated $369M trimmed.
- Renaissance Technologies's largest Q4 2015 buy was Apple: 17,852,932 shares worth $470M.
- Renaissance Technologies added most to Gilead Sciences in Q4 2015, an estimated $212M increase.
- Renaissance Technologies's biggest Q4 2015 reduction was Alphabet (Google) Class C, cutting an estimated $369M.
- Renaissance Technologies fully exited SIGMA - ALDRICH CORP in Q4 2015, selling an estimated $330M.
- Renaissance Technologies's ten largest holdings make up 9.3% of its $45.9B portfolio in Q4 2015.
- Renaissance Technologies opened 509 new positions and closed 386 in Q4 2015.
- Renaissance Technologies's portfolio value rose 9.5% quarter-over-quarter to $45.9B.
Based on Renaissance Technologies's 13F filing for Q4 2015, filed 11 Feb 2016.